Advertisement

Clinical Guidelines for the Assessment and Evaluation of Drugs

  • F. Gross
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 39)

Abstract

At the sixth meeting on Clinical Pharmacological Evaluation in Drug Control, organized by the WHO Regional Office for Europe, it was stated in the “Recommendations” that “the standards and requirements imposed by drug control authorities should be disseminated in the form of concrete guidelines. …various guidelines of this kind, applicable to drugs as a whole or to specific product groups, have been and are being developed both by national organizations and by regional bodies (Benelux, CMEA, EEC). The time is now ripe for steps to be taken to coordinate these activities in order to avoid unnecessary discrepancies. WHO should therefore take measures to collect and compare guidelines of this type and to encourage consultation between the authorities responsible for them. In particular, guidelines for specified groups of drugs can be taken as a basis for discussion at future symposia.”1

Keywords

Antihypertensive Drug Clinical Guideline Drug Control Clinical Investigator Drug Regulator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Clinical pharmacological evaluation in drug control. Report on a Symposium, Deidesheim, 22–25 November 1977. Cophenhagen: WHO, Regional Office for Europe, 1978 (ICP/PHA 004 ).Google Scholar
  2. 2.
    WHO, Regional Office for Europe. Guidelines for evaluation of antihypertensive drugs in man. Europ. J. Clin. Pharmacol. 16: 428–30, 1979.Google Scholar
  3. 3.
    Clinical Pharmacological evaluation in drug control. Report on a Symposium, Deidesheim, 14–17 November 1978. EURO Reports and Studies, No. 13. Copenhagen: WHO, Regional Office for Europe, 1979.Google Scholar
  4. 4.
    Clinical pharmacological evaluation in drug control. Report on a Symposium, Deidesheim, 26–29 October, 1976. Copenhagen: WHO, Regional Office for Europe, 1977 (ICP/PHA 003 ).Google Scholar
  5. 5.
    Guidelines for clinical trials of psychotropic drugs. Pharmacopsychiatrie-Neuro-Psychopharmakologie 10:207–231, 1977 ( J.R. Wittenborn, ed.).Google Scholar
  6. 6.
    Lasagna, L. A plea for the “naturalistic” study of medicines. Europ. J. Clin. Pharmacol. 7: 153–154, 1974.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • F. Gross
    • 1
  1. 1.Department of PharmacologyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations